A detailed history of Dn B Asset Management As transactions in Moderna, Inc. stock. As of the latest transaction made, Dn B Asset Management As holds 52,960 shares of MRNA stock, worth $3.86 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
52,960
Previous 51,913 2.02%
Holding current value
$3.86 Million
Previous $5.53 Million 13.7%
% of portfolio
0.03%
Previous 0.03%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 05, 2024

BUY
$101.21 - $166.61 $105,966 - $174,440
1,047 Added 2.02%
52,960 $6.29 Million
Q1 2024

Apr 12, 2024

SELL
$85.37 - $115.44 $878,286 - $1.19 Million
-10,288 Reduced 16.54%
51,913 $5.53 Million
Q4 2023

Jan 04, 2024

SELL
$69.51 - $104.43 $3.36 Million - $5.04 Million
-48,280 Reduced 43.7%
62,201 $6.19 Million
Q3 2023

Oct 13, 2023

BUY
$96.41 - $126.61 $4.18 Million - $5.49 Million
43,337 Added 64.54%
110,481 $11.4 Million
Q2 2023

Jul 06, 2023

BUY
$118.5 - $160.53 $309,877 - $419,785
2,615 Added 4.05%
67,144 $8.16 Million
Q1 2023

Apr 20, 2023

BUY
$135.66 - $197.02 $398,976 - $579,435
2,941 Added 4.78%
64,529 $9.91 Million
Q4 2022

Jan 12, 2023

BUY
$118.38 - $210.04 $68,423 - $121,403
578 Added 0.95%
61,588 $11.1 Billion
Q3 2022

Oct 11, 2022

BUY
$118.07 - $194.18 $54,076 - $88,934
458 Added 0.76%
61,010 $7.21 Million
Q2 2022

Jul 08, 2022

BUY
$117.13 - $176.59 $242,224 - $365,188
2,068 Added 3.54%
60,552 $8.65 Billion
Q1 2022

Apr 08, 2022

BUY
$126.46 - $235.05 $614,722 - $1.14 Million
4,861 Added 9.07%
58,484 $10.1 Million
Q4 2021

Jan 12, 2022

BUY
$225.82 - $368.51 $1.36 Million - $2.21 Million
6,008 Added 12.62%
53,623 $13.6 Million
Q3 2021

Oct 15, 2021

BUY
$221.9 - $484.47 $1.1 Million - $2.4 Million
4,959 Added 11.63%
47,615 $18.3 Million
Q2 2021

Jul 06, 2021

BUY
$129.91 - $234.98 $581,607 - $1.05 Million
4,477 Added 11.73%
42,656 $10 Billion
Q1 2021

Apr 15, 2021

BUY
$109.18 - $185.98 $18,014 - $30,686
165 Added 0.43%
38,179 $5 Million
Q4 2020

Jan 19, 2021

BUY
$65.74 - $169.86 $307,991 - $795,794
4,685 Added 14.06%
38,014 $3.97 Million
Q3 2020

Oct 14, 2020

BUY
$54.34 - $94.85 $126,720 - $221,190
2,332 Added 7.52%
33,329 $2.36 Million
Q2 2020

Jul 08, 2020

BUY
$29.67 - $80.0 $919,680 - $2.48 Million
30,997 New
30,997 $1.99 Billion

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $28.5B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Dn B Asset Management As Portfolio

Follow Dn B Asset Management As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dn B Asset Management As, based on Form 13F filings with the SEC.

News

Stay updated on Dn B Asset Management As with notifications on news.